贝达奎林:未来可能会发生什么?
Emily S Shaw1, Neil G Stoker2, Jessica L Potter3
1Division of Acute Medical Services, University College London Hospitals NHS Foundation Trust, London, UK.
The Lancet. Microbe
|July 29, 2024
概括
贝达基林为耐药结核病治疗提供了一项突破. 确保全球获取和预防耐药性对于这种重要结核病药物至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 全球健康 全球健康
背景情况:
- 几十年来,结核病药物开发的进展有限.
- 贝达基林代表了重大进展,现在被世界卫生组织推作为抗药结核病的第一线治疗方法.
- 目前的治疗方案提供了更安全,更有效的口服选择.
研究的目的:
- 评估当前关于含贝达基林的疗法证据.
- 识别全球获取障碍和预防药物耐药性的策略.
- 讨论贝达奎林使用的潜在扩张以及未来药物开发的教训.
主要方法:
- 对当前证据的审查.
- 基于国际研讨会 (2023) 的挑战分析.
- 讨论访问问题和阻力问题.
主要成果:
- 含贝达基林的疗法改变了耐药结核病的治疗方法.
- 关键的挑战包括确保全球接入和减轻抗药的兴起.
- 有可能将贝达基林的使用范围扩大到目前的适应症之外.
结论:
- 贝达基林是一种至关重要的工具,但其长期有效性取决于解决访问和抵抗问题.
- 需要进行战略规划,以平衡增加利用率和预防耐药性.
- 从贝达奎林中吸取的经验教导了未来结核病药物的开发和部署.
更多相关视频
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
832
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.8K
相关概念视频
Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Sedatives and Hypnotics Drugs: Benzodiazepines
227
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
227
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Antiepileptic Drugs: Potassium Channel Activators
157
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
157
